“vaccines” Archives

Entry Author Date Location
Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum 03/15/12 Boston
Harvard-Born TremRx Pursues New Vaccine Technology 02/29/12 Boston
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
NanoBio, Merck to Collaborate on Gates-Funded RSV Vaccine 12/09/11 Detroit Ann Arbor
PATH CEO Chris Elias Resigns For Top Anti-Poverty Job at Gates Foundation 10/31/11 Seattle
Sloan-Kettering Spinoff Adjuvance Gains Traction For Vaccine Tech 10/27/11 New York
BIND and Selecta Pull in $50M from Russian Fund Seeking to Advance Nano-Drugs 10/27/11 Boston
BIO Investor Forum Roundup: Immune Design, Sorbent Therapeutics, Epizyme 10/26/11 National
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News 10/20/11 Seattle
GSK Malaria Vaccine Stands Out at Gates Foundation Confab, But Cost Still the Big Question 10/19/11 Seattle
Agenus Rejoices Over Positive Trial of Partner Glaxo’s Malaria Vaccine 10/18/11 Boston
Greenpeace and Michele Bachmann’s Joint Campaign to Stop Science 10/13/11 Seattle
Immune Design Rakes In Another $11M From Prior VC Round 10/05/11 Seattle
Oncothyreon CEO Bob Kirkman Takes Leave, Chairman Chris Henney to Fill In 09/08/11 Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing 09/06/11 Seattle
Jennerex Shows that Unorthodox Cancer-Fighting Virus Can be Delivered the Usual Way 08/31/11 San Francisco
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News 08/25/11 Seattle
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News 08/18/11 San Diego
Scientists Spot New Antibodies Against HIV, Opening Up Potential Path to AIDS Vaccine 08/17/11 National
IDRI Adds Dealmaker 08/03/11 Seattle
There is a New Clinical Trial of a Novel Drug for African Sleeping Sickness. Who Cares? 07/12/11 National
Tachi Yamada, Former Gates Foundation Leader, Joins Frazier for New VC Gig 06/27/11 Seattle
Merck’s Julie Gerberding, Former CDC Director, on the Future of Vaccines 06/24/11 National
PATH Partners With GSK on Malaria Vaccine 06/06/11 Seattle
Geospiza Sells to PerkinElmer, PATH Vaccine Nabs $100M, Halosource Gets China Approval, & More Seattle-Area Life Sciences News 05/12/11 Seattle
PATH Meningitis Vaccine Gets $100M 05/11/11 Seattle
Gates Foundation Dishes Out Latest $100K Grants for ‘Out of the Box’ Global Health Ideas 04/28/11 Seattle
Immune Design Gets New CEO, Seattle Biomed Nabs $9M, VCs Turn Up Heat on FDA, & More Seattle-Area Life Sciences News 04/28/11 Seattle
Seattle Biomed Nabs $9M Gates Foundation Grant to Speed Up Malaria Vaccine Effort 04/27/11 Seattle
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO 04/27/11 Seattle
Page 3 of 9 « previous page · next page »